Gilead Sciences (NASDAQ:GILD)

Big Biotechs Have Short Sellers on the Run

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Goldman Sachs Crushes Value and Turnaround Hopes of Gilead Sciences

Gilead Sciences Inc. (NASDAQ: GILD) quite recently has been considered as both a value stock and as a turnaround candidate for long-term views. Goldman Sachs has muted that upside view ...
Read Full Story »

Major Biotechs See a Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Citigroup Sees Big Upside for 2 of the Largest Biotechs

After quite some time of muted or negative performance, big biotech may be worth a look again. Citigroup analyst Mohit Bansal assumed coverage of the large-cap biotech space and sees ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Stocks were indicated to open lower by about 1%, with the excuse being the same concerns about a trade war with China. Many investors have to be considering if "sell ...
Read Full Story »

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Although the broad markets have been in a slump recently amid China trade talks, the S&P 500 and Dow futures for Tuesday morning were relatively positive. While there has been ...
Read Full Story »

13 Dirt Cheap Dividend Stocks Valued Under 10 Times Earnings

It's been hard filtering out the news from the noise in 2019. After the S&P 500 and Nasdaq Composite recently hit all-time highs and rallying about 20% on average since ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Jefferies Top Stocks to Buy Include 2 Red-Hot Marijuana Companies

For the old-timers on Wall Street and long-time stock investors, the incredible changes in technology and in biotech over the past 25 years have been staggering. Consider that the now ...
Read Full Story »

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

It's no simple task for a biotech giant to try to sell itself to investors as a value stock. That has been the case for some time when it comes ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, April 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

While the overall stock market has been very strong year to date, with sectors like technology outperforming, the health care sector, which encompasses everything from pharmaceuticals to biotech to medical ...
Read Full Story »

Big Biotechs Confound Short Sellers

The short interest data are out for the most recent settlement date, March 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Disney, Gilead, Nordstrom, Novartis, Tesla, Under Armour, Wendy’s and More

Stocks were indicated to open marginally higher in the United States after the European Central Bank kept interest rates steady and forecast that rates would be on hold through at ...
Read Full Story »